Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife’s Technology BEIJING and PARIS, December 21, 2020 – Peijia Medical Ltd (HK Stock Code: 09996) …
VI Partners proudly announces its investment into HighLife Medical. Highlife Medical develops a new 2-component (“valve in ring”) transcatheter mitral valve replacement systems offering unique features for the treatment of …
HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a € 32 …
HighLife SAS, a medtech company focused on the development of a unique trans- catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment …
HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of …
This financing allows for the acceleration of the company’s clinical and R&D program HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement …
